Olema Pharmaceuticals, Inc.

OLMA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$35,260$52,473$50,640$139,480
Short-Term Investments$293,700$309,440$342,067$294,606
Receivables$2,971$2,746$1,920$2,120
Inventory$0$0$0$0
Other Curr. Assets$577$423$276$366
Total Curr. Assets$334,329$367,725$396,663$438,473
Property Plant & Equip (Net)$1,905$2,245$1,708$2,060
Goodwill$0$0$0$0
Intangibles$0$0$739$683
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$16,219$12,032$10,529$9,763
Total NC Assets$18,124$14,277$12,976$12,506
Other Assets$0$0$0$0
Total Assets$352,453$382,002$409,639$450,979
Liabilities
Payables$3,474$934$151$4,460
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$41
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,290$3,392$0$0
Total Curr. Liab.$41,655$33,164$26,064$41,758
LT Debt$3,000$3,000$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$3,310$3,602$123$257
Other Liabilities$0$0$0$0
Cap. Leases$1,478$1,755$1,148$1,429
Total Liabilities$44,965$36,766$26,187$42,015
Equity
Pref Stock$0$0$0$0
Common Stock$7$7$7$6
Retained Earnings-$551,496-$509,279-$465,495-$435,106
AOCI$526$314$420$143
Other Equity$0$0$0$0
Total Equity$307,488$345,236$383,452$408,964
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$352,453$382,002$409,639$450,979
Net Debt-$32,260-$49,473-$50,640-$139,480
Olema Pharmaceuticals, Inc. (OLMA) Financial Statements & Key Stats | AlphaPilot